PNPLA3 and metabolic syndrome: In this study, the main interest is highlighting certain new relations between PNPLA3 genotypes and subclinical atherosclerosis for subjects with diabetes mellitus to confirm or invalidate the specificity of this gene for the stages of hepatic fatty disease as a marker or constituent of metabolic syndrome.